Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...
The 18th International Diabetes Federation (IDF) Congress drew over 15,000 diabetes experts from around the world -- including people living with diabetes. Although it is impossible to guess how many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback